Kodiak Sciences Inc KOD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
3.83UNCH (UNCH)
Volume
2,724
Close
3.83quote price arrow down-0.15 (-3.77%)
Volume
266,916
52 week range
1.37 - 9.80
Loading...
  • Open3.91
  • Day High3.97
  • Day Low3.75
  • Prev Close3.98
  • 52 Week High9.80
  • 52 Week High Date06/07/23
  • 52 Week Low1.37
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap201.209M
  • Shares Out52.53M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta2.47
  • YTD % Change25.99

KEY STATS

  • Open3.91
  • Day High3.97
  • Day Low3.75
  • Prev Close3.98
  • 52 Week High9.80
  • 52 Week High Date06/07/23
  • 52 Week Low1.37
  • 52 Week Low Date10/27/23
  • Market Cap201.209M
  • Shares Out52.53M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta2.47
  • YTD % Change25.99

RATIOS/PROFITABILITY

  • EPS (TTM)-4.97
  • P/E (TTM)-0.77
  • Fwd P/E (NTM)-0.86
  • EBITDA (TTM)-259.023M
  • ROE (TTM)-74.22%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kodiak Sciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high...
Victor Perlroth M.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
John Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Address
1200 PAGE MILL RD
Palo Alto, CA
94304
United States

Top Peers

SYMBOLLASTCHG%CHG
CRVO
CervoMed Inc
24.39-0.01-0.04%
LENZ
LENZ Therapeutics Inc
16.18-0.25-1.52%
ELEV
Elevation Oncology Inc
3.58+0.10+2.87%
XFOR
X4 Pharmaceuticals Inc
1.04-0.05-4.59%
GALT
Galectin Therapeutics Inc
3.24-0.11-3.28%